PARP inhibitor

Related Overviews


More Like This

Show all results sharing this subject:

  • Medicine and Health


Show Summary Details

Quick Reference

A drug that blocks the action of the PARP enzyme, which is required for DNA repair in cancer cells with faulty BRCA1 and BRCA2 genes. Such drugs, including olaparib, are undergoing therapeutic trials for the treatment of cancer in patients with BRCA1 or BRCA2 mutations.

Subjects: Medicine and Health.

Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.